Company
Neuralink
Neuralink is a brain-computer interface (BCI) company founded by Elon Musk in 2016, developing implantable brain chips that enable people with paralysis to…
- Founded
- 2016
- HQ
- Fremont, CA, USA
- Funding
- $650.0M
- Models
- 1
Verified profile
1
Sources on record
0
Tracked changes
Updated recently
Last verified change
Overview
Neuralink is a brain-computer interface (BCI) company founded by Elon Musk in 2016, developing implantable brain chips that enable people with paralysis to control computers and devices with their thoughts. The company's N1 Implant is surgically placed by the R1 Robot, and its PRIME Study began first-in-human trials in January 2024 with patient Noland Arbaugh. Neuralink received FDA Breakthrough Device designation, implanted devices in approximately a dozen patients by late 2025, and raised approximately $1.85B in total funding including a $650M Series E at a $9.6B valuation.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Models (1)
View all models →Current leadership (1)
- Elon Musk Founderreported, not verified
Founders (1)
- Elon Muskcofounder
Safety record
No incidents on record for Neuralink.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Neuralink in third-party press
Peer companies
- Xiaomi3 models
- Baidu2 models
- Brilliant Labs2 models
- Open Bionics2 models
- Plaud AI2 models
- Based Hardware1 model
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series E2025-05-01
$650M(reported) · $9.6B post
Sources (1)
Common questions
- What is Neuralink?
- Neuralink is a brain-computer interface (BCI) company founded by Elon Musk in 2016, developing implantable brain chips that enable people with paralysis to control computers and devices with their thoughts. The company's N1 Implant is surgically placed by the R1 Robot, and its PRIME Study began first-in-human trials in January 2024 with patient Noland Arbaugh. Neuralink received FDA Breakthrough Device designation, implanted devices in approximately a dozen patients by late 2025, and raised approximately $1.85B in total funding including a $650M Series E at a $9.6B valuation.
- Where is Neuralink based?
- Neuralink is based in Fremont, CA, USA.
- When was Neuralink founded?
- Neuralink was founded in 2016.
- What does Neuralink make?
- Neuralink has 1 robot model on the DEPLOY registry: Neuralink N1 Implant (Neuralink builds physical robots).
- Where does Neuralink operate robots?
- Neuralink is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Neuralink safe?
- Neuralink has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-06
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-06
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Neuralink.Peer companies
- Xiaomi3 models
- Baidu2 models
- Brilliant Labs2 models
- Open Bionics2 models
- Plaud AI2 models
- Based Hardware1 model
In the press
Recent coverage mentioning Neuralink from third-party publications. Automatically surfaced; not part of the verified registry record.
Elon Musk Neuralink says it has 21 participants enrolled in trials
Neuralink reported 21 total participants enrolled in clinical trials worldwide, with patients using Neuralink devices to control computers and robotic arms with their thoughts.…
Neuralink secures $650M Series E funding to expand patient access to brain chip technology
Neuralink raised $650M in Series E funding at a $9.6B post-money valuation, bringing total primary funding to approximately $1.85B, to expand patient access to its N1 brain chip…
FDA finds problems at animal lab run by Musk's brain implant company
FDA inspectors found problems with record keeping and quality controls for animal experiments at Neuralink, though the company proceeded with human trials and received FDA…
Machine-readable surfaces
- Markdown mirror: /companies/neuralink.md
- RSS feed: /companies/neuralink/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/01eea241-8b2a-46e5-bdcd-e09761c61c28
- Revision history: /companies/neuralink/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Xiaomi3 models
- Baidu2 models
- Brilliant Labs2 models
- Open Bionics2 models
- Plaud AI2 models
- Based Hardware1 model